Changes in iPSC-Astrocyte morphology reflect Alzheimer's disease patient clinical markers.
Rowland HA. et al, (2024), Stem Cells
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.
Shi L. et al, (2023), Alzheimers Dement
Temporal transcriptional control of neural induction in human induced pluripotent stem cells.
Gupta S. et al, (2023), Front Mol Neurosci, 16
Glycosylated clusterin species facilitate Aβ toxicity in human neurons.
Foster EM. et al, (2022), Sci Rep, 12
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.
Ng B. et al, (2022), Brain Commun, 4
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks.
Zhang Y. et al, (2022), Front Aging Neurosci, 14
Replication study of plasma proteins relating to Alzheimer's pathology.
Shi L. et al, (2021), Alzheimers Dement, 17, 1452 - 1464
High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank.
Sproviero W. et al, (2021), Biol Psychiatry, 89, 817 - 824
Identification of plasma proteins relating to brain neurodegeneration and vascular pathology in cognitively normal individuals.
Shi L. et al, (2021), Alzheimers Dement (Amst), 13
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.
Shi L. et al, (2021), Front Aging Neurosci, 13
Δ9-tetrahydrocannabinol and 2-AG decreases neurite outgrowth and differentially affects ERK1/2 and Akt signaling in hiPSC-derived cortical neurons.
Shum C. et al, (2020), Mol Cell Neurosci
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
Shi L. et al, (2020), J Alzheimers Dis, 77, 1353 - 1368
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
Westwood S. et al, (2020), J Alzheimers Dis, 74, 213 - 225
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Shi L. et al, (2019), Alzheimers Dement, 15, 1478 - 1488
Repressor element 1-silencing transcription factor drives the development of chronic pain states.
Zhang F. et al, (2019), Pain
Convergent molecular defects underpin diverse neurodegenerative diseases.
Tofaris GK. and Buckley NJ., (2018), J Neurol Neurosurg Psychiatry, 89, 962 - 969
Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons.
Robbins JP. et al, (2018), Front Neurosci, 12
Prediction of Chromatin Accessibility in Gene-Regulatory Regions from Transcriptomics Data.
Jung S. et al, (2017), Sci Rep, 7
The Neurogenic Potential of Astrocytes Is Regulated by Inflammatory Signals.
Michelucci A. et al, (2016), Mol Neurobiol, 53, 3724 - 3739